Advertisement

Topics

Companies Related to "Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds" [Most Relevant Company Matches] RSS

07:13 EST 18th November 2018 | BioPortfolio

Here are the most relevant search results for "Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds" found in our extensive corporate database of over 50,000 company records.

Showing "Study Assessing Pharmacokinetics Bioavailability Three Novel Triazine Compounds" Companies 1–25 of 789

Relevant

CHIRAL CHEMICALS

Chiral Chemicals is focused in the business of NUTRACEUTICALS and SPECIALITY FINE CHEMICALS, and we have our objective to consolidate the rich intellectual heritage in chemistry and NATURAL RESOURCES available across India. We supply a wide range of SPECIALITY CHEMICALS as listed below :-Chiral Compounds, Selenium Compound, Phase Transfer Catalysts, Crown Ethers, Pyridine Compounds, Pyrimidine Com...


Pacific Compounds.

Pacific Compounds has the ability to compound an infinite variety of formulations designed to meet the doctor's specific prescription, the patient's individual needs and formulas not commercially available.

Creative Compounds

Creative Compounds is a compounding-only pharmacy that was started in January of 1998. Our goal is to improve the health of our patients by working with them and their practitioners to come up with custom medications that improve therapeutic outcomes. We custom make the proper dose into a dosage form that is best for each patient.


Chemonaut

Chemonaut provides online compound sourcing and procurement services to life science companies. The Chemonaut database is a comprehensive source of commercially available compounds for the most demanding researchers. The online application offers advanced search and filtering functionalities to construct a compound library tailored to your needs. Flexible import and export functions ensure that ...

Sosei Group Corporation

Sosei is an international biopharmaceutical company anchored in Japan with a global reach. It practises a reduced risk business model by acquiring compounds from, and bringing compounds into, Japan through exploitation of its unique position within global markets.For further information about Sosei, please visit www.sosei.com.

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Coagulation Diagnostics Incorporated

Coagulation Diagnostics, Inc. (CDI) develops proprietary diagnostic tests for hypercoagulability, or the tendency to form blood clots. The primary applications for the Company's diagnostic tests include monitoring of novel anticoagulants, assessing the risk of acute myocardial infarction, diagnosing possible reactivation of ischemia, and assessing the risk of clotting following invasive cardiovasc...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Advanced Biomedical Research Incorporated

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in Pennington, New Jersey adjacent to the Princeton biopharmaceutical research corridor. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and...

Pharm PlanNet Contract Research GmbH

Pharm PlanNet Contract Research GmbH (Pharm PlanNet) was founded in 1992 as an independent and privately owned Clinical Research Organisation offering its service to the pharmaceutical industry. Pharm PlanNet is located in central Mönchengladbach (Düsseldorf area), Germany and conducts clinical trials on the safety, tolerance, pharmacokinetics and pharmacodynamics of compounds according to ICH ...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Probably Relevant

Phosphagenics Limited

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products. Phosphagenics’ core technology is built around the science and application of phosphorylation, a process whe...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

The Harvard Clinical Research Institute

The Harvard Clinical Research Institute is a non-profit academic research organization with unparalleled access to resources in clinical research. The Institute advances the research of pharmaceutical, biological, and medical device products by developing collaborations between industry and academia. HCRI’s partners include leading medical centers wit...

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.

GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd, is the leading global provider of ambulant healthcare services for clinical trials to government agencies and the world’s biopharmaceutical and medical device companies engaged in all phases of product development. GlobalCare provides innovative, GCP-compliant services by conducting selected study visits in the home or...

Insert Therapeutics, Inc

Insert Therapeutics is focused on designing, developing and commercializing delivery-enhanced therapeutics using our patented class of polymeric delivery systems, which we have called our "CyclosertT" family of linear cyclodextrin-containing polymers. We are developing proprietary CyclosertT-drug conjugates using off-patent compounds that have documented efficacy, but which also have known issues ...

PharmaLinkFHI, Inc.

PharmaLink provides complete eClinical research services to support and streamline the drug development process. Clinical teams leverage real-time study information to make immediate decisions based on emerging trends and study issues. Our accelerated processes, centralized information management and global reach make it possible to conduct trials of any size or complexity from virtually anywhere....

Synchron

Synchron is a leading Contract Research Organisation in India providing broad range of clinical research services including bioavailability, bioequivalence and pharmacokinetic studies in compliance with GCP, GLP and other applicable guidelines and regulations.

GlycoMark, Inc.

GlycoMark is an FDA-cleared blood test that reveals repeated episodes of postprandial hyperglycemia/glycemic variability by tracking postprandial glucose levels as they related to blood levels of the molecule 1,5-anhydroglucitol (1,5-AG). Multiple published studies indicate that 1,5-AG detects hyperglycemia not detected by the hemoglobin A1C test. A recent study conducted as part of the internat...

ACRO

Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Longboat Clinical

Longboat is a clinical trials software company dedicated to generating better study outcomes by creating a complete support structure for site staff, patients, monitors, and study teams - where protocol compliance becomes easy and instinctive. In the complex world of clinical development, Longboat’s cloud-based site and patient engagement platform emp...

HµREL Corporation

HµREL Corporation is a development-stage enterprise based in Beverly Hills, California. HµREL’s development is proceeding under the aegis of Athena Capital Partners, LLC, a Los Angeles enterprise sponsorship firm (www.athenacapital.net). HµREL is presently inaugurating a Joint Scientific Collaboration (“JSC”), through which a group of global pharmaceutical and consumer products firms will...

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...

TABS Group, Inc.

The 2010 TABS Group Vitamin Study was conducted among 1,000 representative respondents aged 18-75 in the TNS panel. The responses were combined with TABS Group's proprietary modeling capabilities to derive the market size estimates for the Vitamin Category. The study was fielded in May 2010, and it replicated a study that was completed in January 2008. TABS Group is a leading provider of resear...


More From BioPortfolio on "Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks